We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+5.85%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$79.7B
AUM Growth
-$3.54B
(-4.3%)
Cap. Flow
-$8.2B
Cap. Flow
% of AUM
-10.29%
Top 10 Holdings %
Top 10 Hldgs %
14.16%
Holding
2,085
New
185
Increased
629
Reduced
928
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$392M |
| 2 |
Verizon
VZ
|
+$361M |
| 3 |
Occidental Petroleum
OXY
|
+$354M |
| 4 |
Walt Disney
DIS
|
+$162M |
| 5 |
MON
Monsanto Co
MON
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$4.92B |
| 2 |
AstraZeneca
AZN
|
+$621M |
| 3 |
SLM Corp
SLM
|
+$355M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$290M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$278M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.37% |
| 2 | Technology | 14.88% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.74% |
| 5 | Energy | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Halozyme
HALO
$9.92B
| $1.16M | ﹤0.01% |
117,245
+12,000
| +11% | +$102K |
|
1327
POSCO
PKX
$16.6B
| $1.16M | ﹤0.01% |
15,545
| – | – |
|
1328
Stryker
SYK
$128B
| $1.15M | ﹤0.01% |
13,668
+1,827
| +15% | +$149K |
|
|
NWBO
1329
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $1.14M | ﹤0.01% |
169,950
-17,550
| -9% | -$112K |
|
|
LPT
1330
DELISTED
Liberty Property Trust
LPT
| $1.13M | ﹤0.01% |
29,672
+2,754
| +10% | +$104K |
|
|
PES
1331
DELISTED
Pioneer Energy Services Corp.
PES
| $1.12M | ﹤0.01% |
+63,860
| New | +$958K |
|
|
BNY
1332
Bank of New York Mellon
BNY
$108B
| $1.1M | ﹤0.01% |
29,480
+7,759
| +36% | +$268K |
|
1333
Sempra
SRE
$55.2B
| $1.09M | ﹤0.01% |
20,802
+8,316
| +67% | +$413K |
|
|
NAVG
1334
DELISTED
Navigators Group Inc
NAVG
| $1.09M | ﹤0.01% |
+32,480
| New | +$997K |
|
|
EGL
1335
DELISTED
Engility Holdings, Inc.
EGL
| $1.09M | ﹤0.01% |
28,407
-34,296
| -55% | -$1.42M |
|
|
PDCE
1336
DELISTED
PDC Energy, Inc.
PDCE
| $1.08M | ﹤0.01% |
17,145
-4,235
| -20% | -$266K |
|
|
ARRY
1337
DELISTED
Array Biopharma Inc
ARRY
| $1.08M | ﹤0.01% |
236,277
-1,325
| -0.6% | -$5.48K |
|
|
CIE
1338
DELISTED
Cobalt International Energy, Inc
CIE
| $1.07M | ﹤0.01% |
3,906
-308
| -7% | -$84K |
|
|
ATRS
1339
DELISTED
Antares Pharma, Inc.
ATRS
| $1.07M | ﹤0.01% |
400,000
-1,435,234
| -78% | -$4.32M |
|
1340
Nabors Industries
NBR
$1.18B
| $1.06M | ﹤0.01% |
723
+81
| +13% | +$105K |
|
|
ACOR
1341
DELISTED
Acorda Therapeutics
ACOR
| $1.06M | ﹤0.01% |
263
-819
| -76% | -$3.34M |
|
|
B
1342
DELISTED
Barnes Group Inc.
B
| $1.06M | ﹤0.01% |
27,479
| – | – |
|
|
OXF
1343
DELISTED
OXFORD RESOURCES PARTNERS,LP COM UNIT RPSTG LTD PARTNER INT
OXF
| $1.06M | ﹤0.01% |
1,256,617
| – | – |
|
1344
Smith & Wesson
SWBI
$661M
| $1.05M | ﹤0.01% |
94,187
+3,808
| +4% | +$45K |
|
1345
Intercontinental Exchange
ICE
$83.9B
| $1.05M | ﹤0.01% |
27,780
+2,515
| +10% | +$98K |
|
1346
Synopsys
SNPS
$77.1B
| $1.05M | ﹤0.01% |
27,058
+1,686
| +7% | +$64.3K |
|
1347
Myriad Genetics
MYGN
$302M
| $1.05M | ﹤0.01% |
26,890
-579
| -2% | -$21.5K |
|
1348
Nordic American Tanker
NAT
$1.31B
| $1.04M | ﹤0.01% |
+112,013
| New | +$958K |
|
1349
Lithia Motors
LAD
$8.14B
| $1.04M | ﹤0.01% |
11,045
-1,549
| -12% | -$118K |
|
|
PETM
1350
DELISTED
PETSMART INC
PETM
| $1.04M | ﹤0.01% |
17,368
-7,989
| -32% | -$504K |
|
Similar funds
Allianz Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Allianz Asset Management held 2,085 positions worth $79.7B, down 4.3% from $83.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Allianz Asset Management withdrew a net $8.2B in Q2 2014, closing 145 positions and reducing 928 holdings. Its most notable exit was Pentair, an estimated $54.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Allianz Asset Management opened a new position in GSK worth $387M.
- Allianz Asset Management's largest Q2 2014 buy was GSK: 5,790,408 shares worth $387M.
- Allianz Asset Management added most to Verizon in Q2 2014, an estimated $361M increase.
- Allianz Asset Management's biggest Q2 2014 reduction was Bank of America Series L, cutting an estimated $4.92B.
- Allianz Asset Management fully exited Pentair in Q2 2014, selling an estimated $54.1M.
- Allianz Asset Management's ten largest holdings make up 14% of its $79.7B portfolio in Q2 2014.
- Allianz Asset Management opened 185 new positions and closed 145 in Q2 2014.
- Allianz Asset Management's portfolio value fell 4.3% quarter-over-quarter to $79.7B.
Based on Allianz Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.